Unstable angina

When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 21 Dec 2024
Last updated: 25 Apr 2024

Summary

Definition

History and exam

Key diagnostic factors

  • chest pain
  • risk factors for cardiovascular disease
Full details

Other diagnostic factors

  • marked sweating
  • epigastric pain
  • dyspnoea
  • syncope
  • back pain
Full details

Risk factors

  • smoking
  • hypertension
  • diabetes mellitus
  • obesity and metabolic syndrome
  • sedentary behaviour and physical inactivity
  • dyslipidaemia
  • chronic kidney disease
  • atherosclerosis (history of angina, myocardial infarction, stroke, transient ischaemic attack, peripheral vascular disease)
  • family history of premature coronary artery disease
  • age >60 years
  • cocaine use
  • depression
  • stent thrombosis or restenosis
  • sleep apnoea
Full details

Diagnostic investigations

1st investigations to order

  • ECG
  • high-sensitivity troponin
  • chest x-ray
  • full blood count
  • urea, electrolytes, and creatinine
  • liver function tests
  • blood glucose
  • C-reactive protein (CRP)
Full details

Investigations to consider

  • echocardiography
  • invasive coronary angiography
  • functional (stress) testing
  • coronary computed tomography angiography
Full details

Treatment algorithm

ACUTE

suspected or confirmed unstable angina

ONGOING

post-stabilisation

Contributors

Expert advisers

Shrilla Banerjee, MD, FRCP

Consultant Interventional Cardiologist

East Surrey Hospital

Surrey and Sussex Healthcare NHS Trust

UK

Disclosures

SB has received speaker fees for educational lectures (presentation content was her own) and meeting participation from Menarini, Edwards Lifesciences, Abbott Vascular, and Shockwave IVL. She has also participated in an Advisory Board for Sahajanand Medical Technologies Limited. SB has received travel sponsorship from Biosensors International to attend the PCR meeting in Paris in 2022. She has prepared a manuscript on coronary microvascular dysfunction for Abbott for Cardiovascular News (no royalties).

Adam D. Hartley, MBBS, BSc, MRCP

Wellcome Trust Clinical Research Fellow

Imperial College London

Specialist Registrar in Cardiology

Imperial College Healthcare NHS Trust

London

UK

Disclosures

ADH declares that he has no competing interests.

Moad El-Haddad, MBBCh, MRCP

Associate Specialist in Cardiology

East Surrey Hospital

Surrey and Sussex Healthcare NHS Trust

UK

Disclosures

MEH declares that he has no competing interests.

Acknowledgements

BMJ Best Practice would like to gratefully acknowledge the previous expert contributors, whose work has been retained in parts of the content:

Resham Baruah MBBS, BSc MRCP, PhD

Consultant Cardiologist

Chelsea and Westminster Hospital NHS Foundation Trust

Royal Brompton & Harefield NHS Foundation Trust

London

UK

Syed Wamique Yusuf, MBBS, FRCPI

Professor of Medicine

Department of Cardiology

University of Texas

MD Anderson Cancer Center

Houston

TX

Disclosures: RB has received honoraria/speakers' fees from Novartis and Boehringer Ingelheim. SWY declares that he has no competing interests.

Peer reviewers

Gavin Galasko, BM, BCh, MA, DM (Oxon), FRCP

Consultant Interventional Cardiologist

Director of Research, Development and Innovation

Blackpool Teaching Hospitals NHS Foundation Trust

Blackpool

UK

Disclosures

GG declares that he has no competing interests.

Gregory Lip, MD, FRCP, DFM, FACC, FESC, FEHRA

Price-Evans Professor of Cardiovascular Medicine

University of Liverpool

Senior Investigator

National Institute for Health Research

Consultant Cardiologist

Liverpool Heart & Chest Hospital NHS Trust

Liverpool

UK

Distinguished Professor

Faculty of Medicine

Aalborg University

Denmark

Adjunct Professor

Yonsei University

Seoul

South Korea

Disclosures

GL is a consultant for Bayer/Janssen, BMS/Pfizer, Medtronic, Boehringer Ingelheim, Novartis, Verseon, and Daiichi-Sankyo. He is a speaker for Bayer, BMS/Pfizer, Medtronic, Boehringer Ingelheim, and Daiichi-Sankyo. No fees are directly received personally.

Editors

Annabel Sidwell

Section Editor, BMJ Best Practice

Disclosures

AS declares that she has no competing interests.

Susan Mayor

Lead Section Editor, BMJ Best Practice

Disclosures

SM works as a freelance medical journalist and editor, video editorial director and presenter, and communications trainer. In this capacity, she has been paid, and continues to be paid, by a wide range of organisations for providing these skills on a professional basis. These include: NHS organisations, including the National Institute for Health and Care Excellence, NHS Choices, NHS Kidney Care, and others; publishers and medical education companies, including the BMJ Group, the Lancet group, Medscape, and others; professional organisations, including the British Thoracic Oncology Group, the European Society for Medical Oncology, the National Confidential Enquiry into Patient Outcome and Death, and others; charities and patients’ organisations, including the Roy Castle Lung Cancer Foundation and others; pharmaceutical companies, including Bayer, Boehringer Ingelheim, Novartis, and others; and communications agencies, including Publicis, Red Healthcare and others. She has no stock options or shares in any pharmaceutical or healthcare companies; however, she invests in a personal pension, which may invest in these types of companies. She is managing director of Susan Mayor Limited, the company name under which she provides medical writing and communications services.

Rachel Wheeler

Lead Section Editor, BMJ Best Practice

Disclosures

RW declares that she has no competing interests.

Tannaz Aliabadi-Oglesby

Lead Section Editor, BMJ Best Practice

Disclosures

TAO declares that she has no competing interests.

Julie Costello

Comorbidities Editor, BMJ Best Practice

Disclosures

JC declares that she has no competing interests.

Adam Mitchell

Drug Editor, BMJ Best Practice

Disclosures

AM declares that he has no competing interests.

  • Unstable angina images
  • Differentials

    • Stable angina
    • Prinzmetal (variant or vasospastic) angina
    • Non-ST-elevation myocardial infarction
    More Differentials
  • Guidelines

    • 2023 ESC guidelines for the management of acute coronary syndromes
    • Acute coronary syndromes
    More Guidelines
  • Calculators

    GRACE Score for Acute Coronary Syndrome Prognosis

    HAS-BLED Bleeding Risk Score

    More Calculators
  • Videos

    How to perform an ECG animated demonstration

    More videos
  • Patient information

    Unstable angina: what is it?

    Unstable angina: what treatments work?

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer